VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Published on 9 Jan 2025 on Zacks · via Yahoo Finance

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and...

Read the rest of the article

Start tracking your investments with Statfolio

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its...

Benzinga · via Yahoo Finance 10 Jan 2025

Vir Biotechnology ( (VIR) ) has issued an update. Vir Biotechnology announced promising Phase 1...

TipRanks · via Yahoo Finance 9 Jan 2025

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and...

Zacks · via Yahoo Finance 9 Jan 2025

U.S. stocks were lower, with the Dow Jones index falling over 150 points on Wednesday. Shares of ...

Benzinga 8 Jan 2025

Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) surged 29% following the release of encouraging...

Investing.com 8 Jan 2025

Vir Biotechnology Inc (VIR) reports increased R&D expenses due to the Sanofi transaction, while...

GuruFocus.com · via Yahoo Finance 2 Nov 2024

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio ...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

Shareholders in Vir Biotechnology, Inc. (NASDAQ:VIR) may be thrilled to learn that the analysts h...

Simply Wall St. via Yahoo Finance 8 May 2024

Vir Biotechnology, Inc. (VIR) closed the last trading session at $10.22, gaining 7.7% over the pa...

Zacks via Yahoo Finance 7 May 2024

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript May 3, 2024 Vir Biotechnolo...

Insider Monkey via Yahoo Finance 3 May 2024